People with those cancers who took liraglutide, pramlintide, dulaglutide, tirzepatide, lixisenatide, or semaglutide were 38 per cent to 50 per cent less likely to see the disease spread than people who took drugs from a different class of diabetes medicines known as gliptins
Available from: ScienceDirect Tang B, et al
Speak with your licensed healthcare provider about bone health monitoring before and during any GLP-1 treatment
Industry attention remains focused on pipeline acquisitions and licensing as large pharmaceutical companies seek exposure to obesity and metabolic health assets
The whole plant extract of Fimbristylis aestivalis , which contains rosmarinic acid, catechin hydrate, and syringic acid, has inhibitory effects on COX-2 and effectively alleviates inflammatory responses (215)